Ultra high-speed OCT provides minute structural details, potential applications

Article

Ultra high-speed optical coherence tomography (OCT) offers the potential to follow minute changes in patients with various pathologies. Johannes de Boer, PhD, the Wellman Center of Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, reviewed the principles of OCT and the status of ultra high-speed OCT.

Ultra high-speed optical coherence tomography (OCT) offers the potential to follow minute changes in patients with various pathologies. Johannes de Boer, PhD, the Wellman Center of Photomedicine, Harvard Medical School, Massachusetts General Hospital, Boston, reviewed the principles of OCT and the status of ultra high-speed OCT.

"OCT is analogous to ultrasound imaging that uses infrared light instead of sound-the difference between light and sound being that light propagates at five orders of a magnitude faster than sound," Dr. de Boer explained.

"Spectral domain offers a significant advantage over the previous-generation OCT because it provides two to three times better sensitivity," Dr. de Boer said. "Spectral domain OCT allows faster scanning and maintenance of image quality."

One of the first retinal images of 6-µm resolution obtained in the early 1990s provided a 72-fold improvement over the commercial system in speed and 1.5 times in depth resolution. One disadvantage is that the sensitivity of spectral domain OCT is depth-dependent, and the sensitivity decreases by a factor of four at a depth of 1 mm compared with Stratus OCT (Carl Zeiss Meditec), in which the depth response of the system is uniform and the sensitivity is the same. Swept-source OCT can overcome this drawback because the technique uses a laser to obtain the tissue profile.

Dr. de Boer described the potential clinical applications of the technology in glaucoma. He demonstrated that thinning of the superior nerve fiber bundle could be visualized. This may allow clinicians to follow patients with glaucoma over time and offers a comparison of the retinal nerve fiber layer thinning from one time point to another on difference maps.

Clinical application also can be used in patients with age-related macular degeneration because blood clots, subretinal fluid, and suspected choroidal neovascularization can be imaged as well as the scattering of the photoreceptors-leading to a consideration of the changes in the scattering properties of the photoreceptors in these patients and whether these changes are indicative of photoreceptor survival.

Dr. de Boer said that there will be an emergence of increasingly fast OCT systems, but he believes that the technology is limited by the amount of light that is currently introduced into the eye and the resultant quality of the images. He suggested that adding more power in the retina in a shorter amount of time might be a solution.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.